. 2019 May 6;44(9):1639–1648. doi: 10.1038/s41386-019-0407-7

Table 1.

Demographic and clinical characteristics of participants randomized to selective serotonin reuptake inhibitors (SSRI) and cognitive behavioral therapy (CBT) treatments

	SSRI (n = 28)	CBT (n = 27)	Statistic
Demographics
Age in years	29.35 ± 9.97	29.74 ± 8.52	t(53) = −0.16, p = 0.88
Gender (female/male)	22/6	19/8	Χ²(1,N = 55) = 0.15, p = 0.70
Handedness (right/left)	24/4	25/2	Χ²(1,N = 55) = 0.67, p = 0.66
Race			Χ²(4,N = 55) = 3.12, p = 0.40
% Caucasian	78.57	66.67
% African American	14.29	22.22
% Asian	7.14	3.70
% Other/multiracial	0.00	7.41
Principal diagnosis			Χ²(6,N = 55) = 3.83, p = 0.44
% Major depressive disorder/persistent depressive disorder	39.29	18.52
% Generalized anxiety disorder	28.57	48.15
% Panic disorder	3.57	3.70
% Post-traumatic stress disorder	3.57	7.41
% Social anxiety disorder	25.00	22.22
Number of current internalizing disorders	2.54 ± 1.38	2.74 ± 1.48	t(53) = −0.58, p = 0.57
Comorbid diagnoses
% With comorbid current depressive disorder	60.71	59.26	Χ²(1,N = 55) = 0, p = 1
% With comorbid current anxiety disorder	89.29	96.30	Χ²(1,N = 55) = 1.00, p = 0.60
% With comorbid past depressive disorder	17.86	29.63	Χ²(1,N = 55) = 0.50, p = 0.48
% With comorbid past anxiety disorder	17.86	25.93	Χ²(1,N = 55) = 0.16, p = 0.69
Time 1 clinical measures
HAMD total	13.43 ± 5.15	11.89 ± 4.15	t(53) = 1.22, p = 0.23
HAMA total	19.43 ± 7.74	16.37 ± 5.45	t(53) = 1.69, p = 0.09
HAMA psychic anxiety	12.93 ± 3.86	12.00 ± 3.15	t(53) = 0.98, p = 0.33
HAMA somatic anxiety	6.50 ± 4.74	4.37 ± 3.31	t(53) = 1.92, p = 0.06
Time 2 clinical measures
HAMD total	6.07 ± 4.54	4.44 ± 4.12	t(53) = 1.39, p = 0.17
HAMA total	8.18 ± 6.72	5.81 ± 4.92	t(53) = 1.48, p = 0.14
HAMA psychic anxiety	5.68 ± 4.78	4.37 ± 3.31	t(53) = 1.18, p = 0.24
HAMA somatic anxiety	2.50 ± 2.70	1.44 ± 2.41	t(53) = 1.53, p = 0.13

HAMD Hamilton Depression Rating Scale, HAMA Hamilton Anxiety Rating Scale